New leaks have surfaced, giving us an idea of Fortnite collabs in 2026. The list includes anime crossovers like One Piece and other games like Phantom Blade Zero. The leaked skins do not have a ...

Indie movie fans are upset about Google DeepMind’s $75 million investment in the studio, which comes as AI companies are deepening their influence in Hollywood. On the back of this box office coup, it ...

Lego and Pokemon Go are officially collaborating, bringing some exciting exclusive gifts for those who take part. So, if you want to get the most out of the event, here’s all you need to know, ...

Google Colab has taken the data science community by storm. This powerful tool, developed by Google, allows users to write and execute Python code in a web-based environment, making it exceptionally ...

This week, Google AI team released the Colab CLI. The tool connects your local terminal to remote Colab runtimes. It lets developers and AI agents run code on cloud GPUs and TPUs. You stay in your ...

The Google Labs team has cooked up Dreambeans, an app powered by Personal Intelligence and other Google AI capabilities. The app connects to your various Google services, such as Gmail, Calendar, ...

As anyone following Dua Lipa on social media knows, a new photo dump from the singer can only mean one thing: a destination filled with midnight food excursions, aesthetic scenery, and equally ...

At Google I/O 2026, Google opened researcher registration for Hypothesis Generation — the first public-facing tool built on Co-Scientist, its multi-agent AI system for scientific hypothesis generation ...

Two years ago, an AI tool won Google DeepMind a Nobel. Researchers are now climbing toward a new goal. During Tuesday’s Google I/O keynote, Demis Hassabis, the CEO of Google DeepMind, proclaimed that ...

is a senior editor and founding member of The Verge who covers gadgets, games, and toys. He spent 15 years editing the likes of CNET, Gizmodo, and Engadget. They tell me no one outside Google has seen ...

Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital. The raise was also backed by existing investors Alphabet and GV ...